Cyprus vs Mauritius: Cause of death, by non-communicable diseases, ages 15-59
Cyprus
73.9%
in 2021
Mauritius
74.0%
in 2021
Cyprus rank
30th
Mauritius rank
28th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Cyprus
- Mauritius
How they compare
Mauritius currently reports 74.0% against 73.9% in Cyprus, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mauritius ahead.
Cyprus ranks 30th and Mauritius ranks 28th of 185 countries.
Across the 3 decades both report, Cyprus averaged higher in 2 and Mauritius in 1.
Head to head by decade
| Decade | Cyprus | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.8% | 79.0% | 7.2% | Mauritius |
| 2010s | 79.6% | 78.0% | 1.6% | Cyprus |
| 2020s | 77.3% | 75.7% | 1.6% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Cyprus or Mauritius?
- Mauritius, at 74.0% against 73.9% in Cyprus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Cyprus and Mauritius?
- 0.1%, with Mauritius ahead.
- How many years of comparable data are there for Cyprus and Mauritius?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Mauritius rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Cyprus ranks 30th and Mauritius ranks 28th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.